No effective drug treatments are available for coronavirus disease 2019 (COVID-19). Host-directed
therapies targeting the underlying aberrant immune responses leading to pulmonary …

Decompensated liver cirrhosis (LC), a life‐threatening complication of chronic liver disease,
is one of the major indications for liver transplantation. Recently, mesenchymal stem cell (…

Acute-on-chronic liver failure (ACLF) is a severe, life-threatening complication, and new and
efficient therapeutic strategies for liver failure are urgently needed. Mesenchymal stem cell (…

The use of inorganic solid-state electrolytes is considered a viable strategy for developing
high-energy Li-based metal batteries. However, suppression of parasitic interfacial reactions …

Abstract Treatment of severe Coronavirus Disease 2019 (COVID-19) is challenging. We
performed a phase 2 trial to assess the efficacy and safety of human umbilical cord-…

Liver disease encompasses a wide variety of liver conditions, including liver failure, liver
cirrhosis and a spectrum of acute and chronic hepatitis, such as alcoholic, fatty, drug, viral and …

Liver fibrosis and its end-stage consequence, cirrhosis, represent the final common
pathway of virtually all chronic liver diseases. Research into hepatic stellate cell activation, …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has caused a
global pandemic since late 2019 that resulted in more than 360 million population infection. …

A viscous feature is beneficial for a solid electrolyte with respect to assembling solid‐state
batteries, which can change the solid‐solid contacts from point to face. Here, novel halide‐…

A stable interface and preventing dendrite‐growth are two crucial factors to realize long‐life
all‐solid‐state Li batteries (ASSLBs) using sulfide‐based solid electrolytes (SEs) and Li …